Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv).
Taipei, Oct. 26 (CNA) A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.
The US government next month is to require all non-US nationals to be fully vaccinated against COVID-19 before boarding a flight to the nation, but the Taiwanese vaccine manufactured by Medigen Vaccine Biologics Corp (高端疫苗) is not on Washington’s list of acceptable vaccines.
The new international air travel policy, which is to take effect on Nov. 8, requires all non-citizen, non-immigrant air travelers to be fully vaccinated against COVID-19 before flying to the US.
People are considered fully vaccinated two weeks after they receive their second dose in a two-dose series or two weeks after a single-dose vaccine, the White House said.
Vaccines
INCONVENIENT: The US’ new air travel policy requires all non-citizen travelers to be fully vaccinated against COVID-19, but the Taiwanese vaccine is not on the list/ Staff writer, with CNA, WASHINGTON